Last reviewed · How we verify

NCT03566888

Validation of a Noninvasive Automated Blood Pressure Device

Completed Last updated 8 November 2018
What this trial tests

trial testing Blood pressure assessment in Blood Pressure in 85 participants. Completed in 2 October 2018.

Timeline
1 August 2017
Primary endpoint
2 October 2018
2 October 2018

Quick facts

Lead sponsorUniversity of Southern California
StatusCompleted
Study typeOBSERVATIONAL
Enrollment85
Start date1 August 2017
Primary completion2 October 2018
Estimated completion2 October 2018
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Southern California

Who can join

Adults 12 to 92, any sex, with Blood Pressure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigator's objective is to validate the novel automated blood pressure device against the requirements set forth in the AAMI\_ISO 81060-2:2010 standard in voluntarily consented study participants.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Validation of an Automated and Adjustable Blood Pressure System for Use with a Public Health Station.
    Macaulay TR, Erceg DN, McMillan B, Ramirez JE, et al · · 2020 · cited 4× · PMID 32308406 · DOI 10.2147/vhrm.s246401

Verify or expand the search:

Other recruiting trials for Blood Pressure

Currently open trials in the same condition.

Other University of Southern California trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03566888.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing